DRUGS AND ENDOGENOUS LIGANDS COMPETE FOR RECEPTOR OCCUPANCY

被引：5
|
作者：
COLBURN, WA
机构：
[1] Harris Laboratories, Inc., Clinical Development Division, Phoenix, AZ 85040
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1994年 / 34卷 / 12期
关键词：
D O I：
10.1002/j.1552-4604.1994.tb04724.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Dietary and endogenous ligands compete with drugs for receptor occupancy and therefore should be considered during therapeutic interventions and during pharmacokinetic/ pharmacodynamic modeling. When disease is the result of an overabundance of these natural ligands, antibodies and/or their Fab fragments may be useful as therapeutic agents to reverse the effects of the natural ligands.
引用
收藏
页码：1148 / 1152
页数：5
相关论文
共 50 条
  • [11] Physiological roles of endogenous cannabinoid receptor ligands
    Sugiura, T
    Oka, S
    Gokoh, M
    Waku, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 43P - 43P
  • [12] ADENOSINE RECEPTOR LIGANDS - DRUGS OF THE FUTURE
    PEET, NP
    DUDLEY, MW
    HITCHCOCK, JM
    DEMETER, DA
    BORCHERDING, DR
    WEINTRAUB, HJR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 87 - ORGN
  • [13] Imaging D-2 receptor occupancy by endogenous dopamine in humans
    Laruelle, M
    DSouza, CD
    Baldwin, RM
    Abi-Dargham, A
    Kanes, SJ
    Fingado, CL
    Seibyl, JP
    Zoghbi, SS
    Bowers, MB
    Jatlow, P
    Charney, DS
    Innis, RB
    NEUROPSYCHOPHARMACOLOGY, 1997, 17 (03) : 162 - 174
  • [14] Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans
    Marc Laruelle
    Cyril D D’Souza
    Ronald M Baldwin
    Anissa Abi-Dargham
    Stephen J Kanes
    Christine L Fingado
    John P Seibyl
    Sami S Zoghbi
    Malcolm B Bowers
    Peter Jatlow
    Dennis S Charney
    Robert B Innis
    Neuropsychopharmacology, 1997, 17 : 162 - 174
  • [15] Occupancy of agonist drugs at the 5-HT1A receptor
    Bantick, RA
    Rabiner, EA
    Hirani, E
    de Vries, MH
    Hume, SP
    Grasby, PM
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 (05) : 847 - 859
  • [16] Occupancy of Agonist Drugs at the 5-HT1A Receptor
    R Alexander Bantick
    Eugenii A Rabiner
    Ella Hirani
    Michiel H de Vries
    Susan P Hume
    Paul M Grasby
    Neuropsychopharmacology, 2004, 29 : 847 - 859
  • [17] Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
    Di Marzo, V
    Melck, D
    Bisogno, T
    De Petrocellis, L
    TRENDS IN NEUROSCIENCES, 1998, 21 (12) : 521 - 528
  • [18] Modulation of estrogen receptor a levels by endogenous and exogenous ligands
    La Rosa, P.
    Marino, M.
    Acconcia, F.
    JOURNAL OF BIOLOGICAL RESEARCH-BOLLETTINO DELLA SOCIETA ITALIANA DI BIOLOGIA SPERIMENTALE, 2011, 84 (01): : 102 - 103
  • [19] BETA-CARBOLINES - ENDOGENOUS LIGANDS FOR THE BENZODIAZEPINE RECEPTOR
    OGAWA, N
    MORI, A
    FOLIA PSYCHIATRICA ET NEUROLOGICA JAPONICA, 1984, 38 (03): : 207 - 211
  • [20] PROSTAGLANDINS-A AS POSSIBLE ENDOGENOUS LIGANDS OF BENZODIAZEPINE RECEPTOR
    ASANO, T
    OGASAWARA, N
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 80 (2-3) : 271 - 274
12345